Structural dynamics of single Ebolavirus GP molecules.

单个埃博拉病毒 GP 分子的结构动力学。

基本信息

  • 批准号:
    8954151
  • 负责人:
  • 金额:
    $ 179.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-30 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The persistence of the current epidemic is in part a result of the lack of any vaccine, and any approved post- exposure therapies. Progress in the development of such preventative and therapeutic agents has been slow due to a limited understanding of the Ebola viral life cycle. Like all enveloped viruses, entry of Ebolaviruses into target cells requires fusion of the viral membrane to a cell membrane. This process is catalyzed by the envelope glycoprotein (GP). GP is the only viral protein exposed on the surface of Ebola virions, making it an attractive target for vaccines and antiviral therapies. The significant energetic barrier to fusing viral and cell membranes is surmounted by transition of GP to successively lower energy conformations. But virtually no information presently exists on the structural dynamics of GP, the impact of receptor binding on GP conformation, or on the mechanism by which GP catalyzes the fusion of viral and cell membranes. Given the central role of envelope glycoprotein conformational changes in the mechanism of enveloped viral entry, an understanding of Ebolavirus entry requires a deep insight into the conformational landscape of GP. Here, we propose the application of an integrated framework involving smFRET imaging, and kinetic and thermodynamic analysis. We will apply this framework to probe the conformational dynamics of individual trimeric GP molecules on the surface of intact pseudovirions, interrogate their interaction with cellular receptors and antibodies, and elucidate the impact of changes in pH. This approach will bring new light to our understanding of Ebolavirus entry specifically, and enveloped virus entry in general. In addition, we will design GP variants that stably expose antigenic surfaces, and use our smFRET-based framework as a robust and high-throughput means of assaying the conformational landscape of these potential immunogens. We will thereby develop smFRET as a tool for structural vaccine design.


项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James B Munro其他文献

James B Munro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James B Munro', 18)}}的其他基金

Biophysical studies of viral membrane fusion proteins
病毒膜融合蛋白的生物物理学研究
  • 批准号:
    10642837
  • 财政年份:
    2022
  • 资助金额:
    $ 179.06万
  • 项目类别:
Dynamics and mechanisms of filovirus envelop glycoproteins
丝状病毒包膜糖蛋白的动力学和机制
  • 批准号:
    10707317
  • 财政年份:
    2022
  • 资助金额:
    $ 179.06万
  • 项目类别:
Dynamics and mechanisms of filovirus envelop glycoproteins
丝状病毒包膜糖蛋白的动力学和机制
  • 批准号:
    10608034
  • 财政年份:
    2022
  • 资助金额:
    $ 179.06万
  • 项目类别:
Biophysical studies of viral membrane fusion proteins
病毒膜融合蛋白的生物物理学研究
  • 批准号:
    10798382
  • 财政年份:
    2022
  • 资助金额:
    $ 179.06万
  • 项目类别:
Structural dynamics of the HIV-1 genomic 5' UTR
HIV-1 基因组 5 UTR 的结构动力学
  • 批准号:
    9757679
  • 财政年份:
    2018
  • 资助金额:
    $ 179.06万
  • 项目类别:
Structural dynamics of the HIV-1 genomic 5' UTR
HIV-1 基因组 5 UTR 的结构动力学
  • 批准号:
    10102498
  • 财政年份:
    2018
  • 资助金额:
    $ 179.06万
  • 项目类别:
HIV-1 Env antagonism by ground state stabilization
通过基态稳定对抗 HIV-1 Env
  • 批准号:
    9029296
  • 财政年份:
    2015
  • 资助金额:
    $ 179.06万
  • 项目类别:

相似海外基金

Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
  • 批准号:
    10682185
  • 财政年份:
    2023
  • 资助金额:
    $ 179.06万
  • 项目类别:
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial) - An Adaptive Phase II Randomized-Controlled Clinical Trial
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)——适应性 II 期随机对照临床试验
  • 批准号:
    475843
  • 财政年份:
    2022
  • 资助金额:
    $ 179.06万
  • 项目类别:
    Studentship Programs
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial) - An Adaptive Phase II Randomized-Controlled Clinical Trial
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)——适应性 II 期随机对照临床试验
  • 批准号:
    474485
  • 财政年份:
    2022
  • 资助金额:
    $ 179.06万
  • 项目类别:
    Studentship Programs
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
  • 批准号:
    10683329
  • 财政年份:
    2022
  • 资助金额:
    $ 179.06万
  • 项目类别:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
  • 批准号:
    10481430
  • 财政年份:
    2022
  • 资助金额:
    $ 179.06万
  • 项目类别:
An interdisciplinary approach towards antiviral therapy discovery
抗病毒疗法发现的跨学科方法
  • 批准号:
    nhmrc : 1196520
  • 财政年份:
    2021
  • 资助金额:
    $ 179.06万
  • 项目类别:
    Investigator Grants
Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapy
应用“组学”方法预测退伍军人在使用直接作用抗病毒疗法治愈 HCV 后的肝失代偿事件和肝细胞癌
  • 批准号:
    10260234
  • 财政年份:
    2021
  • 资助金额:
    $ 179.06万
  • 项目类别:
Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapy
应用“组学”方法预测退伍军人在使用直接作用抗病毒疗法治愈 HCV 后的肝失代偿事件和肝细胞癌
  • 批准号:
    10548114
  • 财政年份:
    2021
  • 资助金额:
    $ 179.06万
  • 项目类别:
Disparities in the Diffusion of Direct-Acting Antiviral Therapy for Hepatitis C among Baby Boomers: A Mixed-Methods Study
婴儿潮一代丙型肝炎直接作用抗病毒疗法传播的差异:一项混合方法研究
  • 批准号:
    10400318
  • 财政年份:
    2020
  • 资助金额:
    $ 179.06万
  • 项目类别:
Development of novel antiviral therapy targeting hepatitis B virus host restriction factor
针对乙型肝炎病毒宿主限制因子的新型抗病毒疗法的开发
  • 批准号:
    20K08371
  • 财政年份:
    2020
  • 资助金额:
    $ 179.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了